Number of Credits
This course provides information and interactions that facilitate learning about ways laboratory professionals can prevent medical errors and ensure patient safety.
Most medical interventions produce positive outcomes. Everyone expects to give and receive effective medical care. These expectations are routinely met by the health care community.
However, a 2000 publication from the Institute of Medicine, (IOM), To Err is Human: Building a Safer Health System, reported that between 44,000 and 98,000 individuals died while hospitalized in the United States in 1997 due to medical error. Deaths occurred due to medication errors, nosocomial infections, and other failures in the delivery of care.
For patients who do not die, yet experience a medical error during their hospital stay, at the minimum they experience repetitive testing and procedures and extended hospital stay. These increase overall costs to health insurance companies and individuals; at the worst, they may leave a patient with a comorbidity or disability. Using unnecessary resources to address these errors reduces opportunities to provide care for uninsured individuals, add new technology, or support new programs.
Although there has been a greater focus upon reducing errors in hospital settings, medical care delivered in outpatient and other non-hospital settings are not immune from error prone systems.
It has been several years since the IOM published To Err is Human, but the IOM’s messages and recommendations continue to be opportune. Health care practitioners and patients may be more aware of these recommendations today, however, serious adverse events continue to occur in health care organizations throughout the country.
- List and describe the six aims of the Institute of Medicine (IOM) to improve health care quality.
- Describe the IOM aims within the context of quality clinical laboratory services.
- Define “total testing process” and recognize problems (errors) that could occur in each phase of the total testing process.
- Identify outcomes of patient safety errors with respect to clinical laboratory services.
- Discuss patient safety goals.
This CME activity has been designed to change learner competence and focuses on the American Board of Medical Specialties areas of patient care, practice-based learning and systems-based practice.
This Enduring Material activity, Laboratory Director Continuing Education Program, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 08/01/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Approved for 2.0 AAFP Prescribed credits.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
This course will take 2 hours to complete and there are no prerequisites. A credit certificate will be issued upon completion of the course evaluation and post-test with a score of 80% or better.
Release Date: 8/1/2017
Expiration Date: 8/1/2018
- Six aims of the Institute of Medicine (IOM) to improve health care quality.
- IOM aims within the context of quality clinical laboratory services.
- Recognizing problems (errors) that could occur in each phase of the total testing process
- Outcomes of patient safety errors with respect to clinical laboratory services.
- Sources of data to identify errors and patient outcomes
- Patient Safety Goals
- Graded Exam
Free, current version of Internet Explorer, Chrome, Firefox, or Safari. (Some older browsers could produce error messages or not display the content correctly.)
Free, current version of Adobe Flash Player and Adobe Reader.
Faculty, authors, planners and other persons who may influence the content of this CME activity must disclose all relevant financial relationships with commercial interests in order for CME staff to identify and resolve any potential conflicts of interest. Any planned discussions of unlabeled/unapproved uses of drugs or devices must also be disclosed.
The course planner and reviewer Verlin K. Janzen, MD, FAAFP has no relevant financial relationships to report. There will be no discussions of unlabeled/unapproved uses of drugs or devices in this online learning course.